000 | 02636nam a2200253Ia 4500 | ||
---|---|---|---|
003 | NULRC | ||
005 | 20250520100634.0 | ||
008 | 250520s9999 xx 000 0 und d | ||
020 | _a9781455710270 | ||
040 | _cNULRC | ||
050 | _aRC 111 .I54 2011 | ||
100 |
_aAmital, Howard _eauthor |
||
245 | 0 |
_aInfectious disease clinics of North America : _bbiologic response modifiers in infectious disease / _cHoward Amital [and twenty-three others]. |
|
260 |
_aPhiladelphia, Pennsylvania : _bSaunders an imprint of Elsevier, Inc., _cc2011 |
||
300 |
_axiv, 719 - 921 pages : _billustrations ; _c23 cm. |
||
365 | _bPHP6600 | ||
490 | _vVolume 25 : Number 4. | ||
504 | _aIncludes index. | ||
505 | _aBiologic Response Modifiers: Relevance & Repercussions -- Overview of Biologic Response Modifiers in Infectious Disease -- Role of Endogenous Biological Response Modifiers in Pathogenesis of Infectious Disease -- Vaccines and Vaccine Adjuvants as Biological Response Modifiers -- Polyclonal Immunoglobulins and Hyperimmune Globulisms in Prevention and Management of Infectious Diseases -- Monoclonal Antibodies in Infectious Diseases: Clinical Pipeline in 2011 -- Colony-Stimulating Factors in the Prevention and Management of Infectious Diseases -- Interferons as Therapeutic Agents for Infectious Diseases -- Mediators of Systematic Inflammatory Response Syndrome and the Role of Recombinant Activated Protein C in Sepsis Syndrome -- The Common Immunogenic Etiology of Chronic Fatigue Syndrome: From Infections to Vaccines via Adjuvants to the ASIA Syndrome -- Mycobacteria and Biological Resopnse Modifiers: Two Sides of the Relationship -- Biologics and Infections: Lessons from Tumor Necrosis Factor Blocking Agents -- Index. | ||
520 | _aBiologic response modifiers (BRMs) are substances that stimulate the body's response to infection and disease. The body naturally produces small amounts of these substances. Scientists can produce some of them in the laboratory in large amounts for use in treating infections and other diseases. This issue reviews the use of BRMs to treat infectious diseases as well as the infectious complications of BRMs used to treat non-infectious diseases. Articles on vaccines, antibodies, interferon, and other substances are included. | ||
650 | _aBIOLOGICAL RESPONSE MODIFIERS | ||
700 |
_aBergman, Scott;Ferguson, Mckenzie C.;Hsu, Jennifer L.;Kak, Vivek;Khardori, Nancy Misri;Khardori, Romesh;Koirala, Janak;Khardori, Nancy Misri ;Moellering, Jr., Robert C. _eco-author;co-author;co-author;co-author;co-author;co-author;co-author;guest editor ;consulting editor |
||
942 |
_2lcc _cBK |
||
999 |
_c10161 _d10161 |